Press Releases
Santa Barbara Based And Worldwide Distributed Protocol Receives Patent

Santa Barbara, California- 2/7/2010- The Wiley Protocol, headquartered in Santa Barbara, CA. has received patent #7,879,830. Ten years after the first in lab experiments with progesterone and breast cancer cells, seven years after the publication of Sex, Lies and Menopause and the creation of the Wiley Protocol for women, the USPTO has recognized the Wiley Protocol as unique with its recent patent ruling : The Wiley Protocol  # 7,879,830.

Patented for treatment using a 28-day biomimetic, variable dose cycling bio-identical hormone therapy protocol, this ground-breaking ruling paves the way for greater standardization of compounded medicines, including standardized dose modification, which increases safety for women, and complete protection for patients who wish to utilize WP for therapy. Patients can now be assured they are getting the real Protocol made by trained pharmacists and dispensed by knowledgeable physicians.

T.S. Wiley commented about the patent, “This is a land mark moment for singular scientists everywhere. Until this moment, the only patented treatments for the bioidentical hormone treatment of menopause and related disease states have come from big pharmaceutical companies. The Wiley Protocol for Women is the beginning of real Feminist Medicine."

It's a nod toward the unique nature, long term clinical results, and peer-reviewed science driven approach that the Wiley Protocol entails. We will continue to study BHRT in this now patent-protected environment for the good of all women.

Wiley’s revolutionary discovery that it may be the rhythm that matters in the accurate physiological replacement of hormones may have important implications across a wide range of areas, from the treatment of menopause and anti-aging to other diseases of
aging including heart disease and stroke, Type II diabetes, cancer and Alzheimer’s disease. Physicians and Pharmacists who join our project can, too, now be assured of governmental co-operation to produce quantity medical care. T.S. Wiley and her team of experts offer seminars around the world.

Wiley Systems, Inc. founded in Santa Barbara, CA in 2005, began as a project to unite doctors and pharmacists in a common goal to standardize bio-identical hormones for academic research.

 

The Wiley Protocol(R) is a trademarked, patent protected bio-identical hormone replacement therapy (HRT) delivery system consisting of biomimetic estradiol and progesterone in a topical cream preparation – dosed to mimic the natural hormones produced by a woman's body when she was in her prime. The Wiley Protocol was developed by T.S. Wiley, a popular author and frequent speaker at medical seminars around the world.

 

###

 
The Wiley Protocol Is Now Available to Women In Europe

Wiley Systems is partnering with N.PSATHAS & CO Pharmacy. The partnership will bring the Wiley Protocol to over 11 million residents of Greece and into Europe.

"Greece, an icon of Western Civilization’s philosophical origins in both medicine and science, is an ideal location to begin to support our expanding distribution needs in Europe," said T.S. Wiley, CEO of Wiley Systems.

"We want to thank Nikolaus Psathas and N.PSATHAS & CO. Pharmacy for their vision in supporting and partnering with us. We look forward to a long and prosperous relationship with major expansion into Europe."

N. PSATHAS & CO. Pharmacy was founded in 2006 in Halandri, Athens and is headquartered in one of the areas of major growth in north Athens.

N.PSATHAS & CO. Pharmacy has divisions specializing in medicines, cosmetics, and supplements. Their new pharmaceutical laboratory is ISO 9001 certified, with the most technologically advanced equipment for compounding. This cutting edge laboratory produces all combinations of Wiley Protocol hormones as well as a large number of supplements and vitamins.

"This is great health news for the residents of the entire region and could not have come at a better time," said Zoe Raden, COO of Wiley Systems. "After years of hard work to develop distribution into Europe, the result has now come to fruition. This breakthrough into Europe will help thousands enjoy a better quality of life through bio‐identical hormone replacement therapy."

N. PSATHAS & CO. Pharmacy will finalize their training for the Wiley Protocols on Thursday, July 22nd, 2010.


About Wiley Systems, Inc.
Wiley Systems, Inc. was founded in 2005 in Santa Barbara, California by T.S. Wiley, who is the developer of the Wiley Protocol®, a trademarked patent protected delivery system consisting of biomimetic, bio‐identical hormones.

Wiley Systems began as a project to unite doctors and pharmacists in a common goal to standardize bioidentical hormones for academic research. The Wiley Protocol is only available at compounding pharmacies that have joined the project for future National Institutes of Health (NIH) study and have contractually agreed to the standardized methods, materials, packaging and recommended pricing. In exchange, Wiley Systems provides intellectual property and provides 28WP logo‐bearing packaging consisting of color‐coded bags and applicators.

The Wiley Protocol name assures customers that they are receiving authentic Wiley Protocol dosing rhythms based on original research. Now in 2010, the Wiley Pharmacy Consortium numbers over 50 pharmacies and more than 300 doctors prescribing in the US, Canada, Australia and Europe.

Zoe Raden
Wiley Systems
1-800-929-WILEY
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 
New Web Site Launches: News Release
SANTA BARBARA, CA-- (PRWeb April 23, 2010) – Wiley Systems is pleased to announce the launch of two new websites, it’s new and improved consumer site www.thewileyprotocol.com. and www.wileyprotocolsystems.com, it’s brand new provider and pharmacist website.

These sites are the result of one year of analysis, design, and programming. Our goal is to provide our visitors with a virtual experience that is compelling and informative.

The consumer site now features an interactive, up-to-date calendar of events where visitors can get automated reminders for programs. Visitors can now also easily access archival and cross-referenced information. For example, information from lectures and symposia are available from as early as 2005 and the most current Wiley Protocol rhythms.

In addition to the site’s many new technical features, the graphic design and interface present a dramatic improvement. We have streamlined the site’s navigation, making it more intuitive and user-friendly. We also created a visual navigation system for the many visitors who simply want to browse around the site without a specific destination.

The doctor and pharmacist site enables our online visitors an easy, instant, and secure way to register for programs, and purchase products from Wiley Systems.  Both sites allow the visitor to find an authorized Wiley Protocol medical provider and Wiley registered pharmacy, thus allowing the visitor the easy ability to locate the protocol in their local areas and regions. We have also implemented bookmarking and social media tags are also embedded throughout both sites so that visitors receive news and information with others on sites like Facebook,Twitter, and De.ici.us.

We think this dual presentation will allow our "power users" the ease and efficiency of rapidly getting to their resources, while simultaneously inviting millions of new visitors to learn more about the built environment as they can casually browse through articles, media, and archives.

In the coming months, we will be introducing new site features including customizable pages populated with visitor defined content, and so much more.

 

About Wiley Systems, Inc.

Wiley Systems, Inc. was founded in 2005 in Santa Barbara, California by T.S. Wiley, who is the developer of the Wiley Protocol®, a trademarked patent protected delivery system consisting of biomimetic, bio-identical hormones.

The Wiley Protocol is only available at compounding pharmacies that have joined the project for future National Institutes of Health (NIH) study and have contractually agreed to the standardized methods, materials, packaging and recommended pricing. In exchange, Wiley Systems provides intellectual property and provides 28WP logo-bearing packaging consisting of color-coded bags and applicators. The Wiley Protocol name assures customers that they are receiving authentic Wiley Protocol dosing rhythms based on original research.

Wiley Systems began as a project to unite doctors and pharmacists in a common goal to standardize bioidentical hormones for academic research. Now in 2010, the Wiley Pharmacy Consortium numbers over 50 pharmacies and more than 300 doctors prescribing in the US, Canada, Australia and Europe.

 
T.S. Wiley to Testify Before the Select Committee on Aging at the US Senate
Santa Barbara, CA (PRWeb) April 19, 2007–

T.S. Wiley has been asked to testify today before the Select Committee on Aging at the United States Senate today in Washington D.C. She will present her expertise and experience with menopause and bio-identical hormone replacement therapy, and the changing landscape of women’s health in later years, among other research. Wiley is a medical theorist in the field of Darwinian Medicine or “environmental endocrinology” and a writer and researcher on the use of hormones, particularly in postmenopausal women.

Wiley addresses the fact that the Safe Compounding Drug Act of 2007 would severely restrict and possibly deny access to critical medications and give the Food and Drug Administration the power to:

Broadly eliminate the availability of many critical, commonly compounded medications that many patients rely on (most especially bio-identical hormones for women).
Determine when compounded medicines are needed - a decision that has always been and should always be made by doctors.
Restrict the compounded medications the doctor can prescribe even if he or she determines the need for them.


“Among those left with little or no choice will be menopausal women and andropausal men; the Autistic community; individuals living with HIV/AIDS; infants and young children with conditions like gastroesophageal reflux disease (GERD); hospice and nursing home patients; people who are extremely allergic or sensitive to fillers, dyes, and additives in medicines, and head trauma victims whose lives and minds can be saved by a compounded bio-identical hormone,” Wiley said. “Please don’t let this happen.”

T.S. Wiley is the author of “Sex, Lies & Menopause,” Harper Collins, 2005, a landmark work where a doctor, a philosopher, and a scientist prove that by postponing marriage and motherhood, women have accelerated the aging process, resulting in earlier menopause and, ultimately for thousands, earlier death. The book also examines the introduction of the birth control pill in the early 1960’s and the impact of not breast-feeding our young.

There are over 40 million women between the ages of 40 and 60 in the U.S. About 25 million women worldwide enter menopause annually. It is estimated that by the year 2030, that number will increase to 47 million women per year. Since 1900, in the developed countries, the life expectancy of women has increase from age 47 to well over age 80, however, the average onset of menopause has remained at 50 as recorded for the last 150 years. That means, overall, women are living at least thirty years longer than they did at the turn of the century.

“Given the evidence that the symptoms of menopause, which can begin for women as early as their late thirties, are the same as the daily challenges the elderly face – that we become, in fact, old, when our hormones start to plummet – we can probably assume we’re going to be sick, too, if we aren’t already,” said Wiley.

Wiley says that menopause, and andropause in men, are states of hormone depletion akin to the failure of Type I diabetics to produce insulin from their own pancreas. “Type I diabetics take a bio-identical molecule of insulin, using a short needle, through their skin, dosing it as their bodies would have produced it – after a meal, depending on what the meal consisted of, and they live long, pretty comfortable, healthy, productive lives. Yet medicine refuses to acknowledge the obvious–that the replacement of sex hormones in the same manner might put a serious dent in the diseases of old age.”

Wiley’s address to the Committee points out that the Women’s Health Initiative (WHI), now the “gold standard” regarding hormone therapy, never looked at hormones, only drugs with “hormone-like” effects that were dosed in a regimen far from that of human replacement. Since this study, everybody seems to know estrogen causes cancer. She asks,   “Do we know that, or, have we just been told that?”

Since the National Institutes of Health (NIH) stopped the Women’s Health Initiative (WHI) in 2003 because the synthetic hormones – Premarin and PremPro were deemed too dangerous, the common assumption among women using bio-identical regimens is that they are doing something “safer.” However, Wiley points out that the synthetics may have caused the harm reported, not just because they weren’t bio-identical hormone molecules, but because of the way they were statically dosed. Perhaps, bio-identicals, currently dosed in the Standard of Care mode, may, too, be in need of study and improvement for safety.

“If estrogen and progesterone, or even testosterone, caused cancer, all young women would be dead. They’re full of these hormones. So if logic tells us that estrogen doesn’t actually cause cancer in and of itself, then there must be more to the story—like what kind and how much estrogen and when to take it,” claims Wiley.

In Wiley’s opinion, the failure of the WHI trial is partially due to the lack of understanding of the biology of the reproductive and menopausal state as well as, the indiscriminant choice of study subjects without well defined entry criteria, such as on the average enrolling subjects 12 to 15 years into menopause. She also questions the administration of drug molecules that are not natural to women’s bodies as compounded versions of plant-derived hormones could be.

“The choice of the molecule, the dosage, and timing of the onset of therapy are the most important variables in the search for safe and effective HRT and the WHI spent almost a billion dollars and never approached any of the most important questions,” said Wiley.

Furthermore, researchers Grady and Rubin looked at 85 percent of the world’s data on estrogen and cardiovascular effects and found that the positive cardiovascular effect of estrogen in decreasing blood pressure and lipid profiles was unparalleled by pharmacological agents. Wiley asks if just lack of hormones explains why the rate of heart attack among women in this country is ten times less than it is in men until menopause or, if possibly the epidemic of breast cancer from forty on in women?

She also asks, “If hormone replacement consisted of real bio-identical hormones and was dosed to mimic the ups and downs of the blood levels seen in a healthy menstrual cycle of a 20 year-old woman, would all of the symptoms and disease states of aging decline or even, disappear?"

Beverly Hills, California-based medical practitioner, Dr. Christian Renna said, “I believe that T.S Wiley has made one of the most important discoveries in this century- a simple molecular mechanism that up until now, everyone else has missed.”

Wiley’s revolutionary discovery is the fact that it’s the rhythm that matters in the accurate physiological replacement of hormones without side-effects for women in the second half of life. Wiley’s findings may have important implications across a wide range of areas, from the treatment of menopause and anti-aging to all of the other diseases of aging such as heart disease and stroke, Type II diabetes, cancer and Alzheimer’s disease.

The heart of Wiley’s endocrine research in women is based in chronobiology and circadian rhythmicity. Her work rests on the simple fact that the circadian clock in every cell of every human body measures one spin of the earth, and the planet’s constant companion, the moon, tracks 28 days 13 times in one revolution around the sun.

This light and dark cycle response on hormone receptors has evolved the 28 day menstrual cycle embedded in the physiological make-up of all women. That’s why replacing hormones for women with static one-time-a-day, same-amount-every-day, dosing has been so unsuccessfully lethal that most women get sick and some women die whether they take synthetic or bio-identical hormones in such a non-natural regimen.
After years of research, T.S. Wiley developed a new method of hormone replacement therapy (HRT) called the Wiley Protocol® for women to use as a more accurate form of replacement for lost endocrine function. The Wiley Protocol is a patent protected delivery system consisting of bio-identical estradiol and progesterone in topical cream preparations dosed to mimic the natural hormones produced by a twenty year-old woman. The creams and their amounts vary throughout the 28 day cycle to mimic the hormone levels of youth. The Protocol is the only bio-identical hormone replacement therapy (BHRT) that has ever been developed under the scrutiny of a practicing oncologist.

Mounting evidence on the Wiley Protocol shows that it was the rhythm that was always missing in other regimens, and T.S. Wiley, Inc. is now waiting for a study number from the University of Texas at Tyler’s Nursing School’s IRB Committee. The proposed study is a longitudinal, observational study measuring many of the parameters of the WHI in women currently using the Wiley Protocol.

Wiley’s testimony also mentions that the National Institute of Neurological Diseases and Stroke is expected to approve and fund a national clinical trial this summer designed to see if high doses of compounded progesterone, a hormone that is present in all human brains, can help disrupt the rapid death of brain cells that frequently follows a trauma to the head. The quest for neuroprotection is driven not only by a deepening understanding of how injury and disease damage the human brain but, by a growing sense of urgency due to the almost 1,900 U.S. soldiers who have been treated for traumatic brain injury. Some Pentagon estimates have suggested that as many as 28 percent of the 1.4 million troops that have served in Iraq and Afghanistan may have sustained at least mild brain injury from the concussive effects of bomb blast.

At the same time, seventy-eight million baby boomers are reaching the peak years for stroke and degenerative brain diseases. Already, in the United States each year, 700,000 Americans suffer a stroke, and as many as 500,000 are diagnosed with a neurodegenerative disease (1.4 million suffer a traumatic brain injury). Such numbers have helped propel the search for an agent that could limit or hold off disability across a range of illnesses.

T. S. Wiley spent eight years in private tutorial in molecular biology with Dr. Bent Formby, PH. D., and has been in clinical private tutorial in oncology with Dr. Julie Taguchi since 1998. She has also been a guest investigator at Sansum Medical Research Institute, Santa Barbara, CA.

About Wiley Systems

Founded in 2003 in Santa Barbara, California T.S. Wiley, Inc. is the developer of The Wiley Protocol®, a trademarked patent protected delivery system consisting of bio-identical estradiol and progesterone in topical cream preparations dosed in a rhythm to mimic the natural cyclic hormone levels replicated in serum blood produced by a twenty year-old woman.

The only bio-identical hormone replacement therapy (BHRT) that has ever been developed under the scrutiny of a practicing oncologist, The Wiley Protocol is only available at compounding pharmacies that have agreed to the standardized methods, materials, packaging and recommended pricing. In exchange, Wiley Systems™ provides intellectual property and sells pre-stamped 28WP logo-bearing packaging consisting of bags, labels and syringes in the branded colors of purple and green. The Wiley Protocol name, assures customers that they are receiving the authentic Wiley Protocol.

As a medical writer and researcher in chronobiology, environmental endocrinology and circadian rhythmicity, T.S. Wiley is the author of “Sex, Lies & Menopause,” Harper Collins, 2005 and Lights Out: Sleep, Sugar and Survival,” Pocket Books, 2000. Wiley’s CME accredited seminars on the natural history of endocrinology are attended by physicians from all over the world who are learning about The Wiley Protocol. Wiley’s revolutionary discovery that it may be the rhythm that matters in the accurate physiological replacement of hormones may have important implications across a wide range of areas, from the treatment of menopause and anti-aging to all of the other diseases of aging such as heart disease and stroke, Type II diabetes, cancer and Alzheimer’s disease.

Click Here To View The Entire Special Committee Hearing On Aging

 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  Next 
  •  End 
  • »


Page 1 of 3

The Wiley Protocol System For Providers And Pharmacists

Wiley Protocol® Rhythms